A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?

BACKGROUND: The World Health Organization aims to reduce tuberculosis (TB) mortality rate from 15% in 2015 to 6.5% by 2025. AIM: This study determined the profile of TB and human immunodeficiency virus (HIV) co-infected patients who died in Mahalapye District, Botswana, while on anti-TB medication a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tshitenge, Stephane, Ogunbanjo, Gboyega A., Citeya, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244457/
https://www.ncbi.nlm.nih.gov/pubmed/30456967
http://dx.doi.org/10.4102/phcfm.v10i1.1765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244457/
https://www.ncbi.nlm.nih.gov/pubmed/30456967
http://dx.doi.org/10.4102/phcfm.v10i1.1765

Ejemplares similares